RARE logo

RARE Non Current Assets

Annual Non Current Assets

$713.90 M
+$52.36 M+7.91%

December 31, 2023


Summary


Performance

RARE Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRAREbalance sheetmetrics:

Quarterly Non Current Assets

$738.75 M
+$84.96 M+12.99%

September 30, 2024


Summary


Performance

RARE Quarterly Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRAREbalance sheetmetrics:

Non Current Assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

RARE Non Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+7.9%+15.6%
3 y3 years+53.8%+15.8%
5 y5 years+262.0%+177.3%

RARE Non Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+7.9%-2.6%+21.9%
5 y5-yearat high+150.9%-2.6%+159.7%
alltimeall timeat high>+9999.0%-2.6%>+9999.0%

Ultragenyx Pharmaceutical Non Current Assets History

DateAnnualQuarterly
Sep 2024
-
$738.75 M(+13.0%)
Jun 2024
-
$653.80 M(-8.1%)
Mar 2024
-
$711.11 M(-6.3%)
Dec 2023
$777.11 M(-12.1%)
$758.83 M(+18.8%)
Sep 2023
-
$638.95 M(+4.9%)
Jun 2023
-
$609.17 M(-1.3%)
Mar 2023
-
$617.07 M(-6.7%)
Dec 2022
$883.90 M(+3.2%)
$661.54 M(+9.2%)
Sep 2022
-
$605.81 M(-5.7%)
Jun 2022
-
$642.09 M(-5.1%)
Mar 2022
-
$676.51 M(+1.6%)
Dec 2021
$856.60 M(-33.9%)
$665.79 M(+4.4%)
Sep 2021
-
$637.92 M(+13.3%)
Jun 2021
-
$562.95 M(+6.9%)
Mar 2021
-
$526.83 M(+13.5%)
Dec 2020
$1.30 B(+52.2%)
$464.25 M(+17.1%)
Sep 2020
-
$396.38 M(-2.8%)
Jun 2020
-
$408.00 M(+20.4%)
Mar 2020
-
$338.82 M(+19.1%)
Dec 2019
$851.02 M(+62.9%)
$284.48 M(+6.8%)
Sep 2019
-
$266.46 M(+2.7%)
Jun 2019
-
$259.50 M(+17.5%)
Mar 2019
-
$220.87 M(+12.0%)
DateAnnualQuarterly
Dec 2018
$522.37 M(+93.8%)
$197.19 M(-0.2%)
Sep 2018
-
$197.66 M(-1.8%)
Jun 2018
-
$201.28 M(-14.6%)
Mar 2018
-
$235.77 M(+6.6%)
Dec 2017
$269.58 M(-32.9%)
$221.17 M(+401.0%)
Sep 2017
-
$44.14 M(-43.2%)
Jun 2017
-
$77.75 M(-23.1%)
Mar 2017
-
$101.14 M(-27.2%)
Dec 2016
$401.69 M(-10.8%)
$138.93 M(+41.2%)
Sep 2016
-
$98.38 M(+38.8%)
Jun 2016
-
$70.87 M(-24.6%)
Mar 2016
-
$93.95 M(-14.1%)
Dec 2015
$450.21 M(+132.8%)
$109.36 M(-22.7%)
Sep 2015
-
$141.42 M(+2084.5%)
Jun 2015
-
$6.47 M(+21.6%)
Mar 2015
-
$5.33 M(+17.0%)
Dec 2014
$193.42 M(+250.2%)
$4.55 M(+8.6%)
Sep 2014
-
$4.19 M(-4.1%)
Jun 2014
-
$4.37 M(+42.3%)
Mar 2014
-
$3.07 M(-30.6%)
Dec 2013
$55.23 M(-36.1%)
$4.42 M(+130.8%)
Sep 2013
-
$1.92 M(+2.5%)
Dec 2012
$86.44 M(+689.2%)
$1.87 M
Dec 2011
$10.95 M
-

FAQ

  • What is Ultragenyx Pharmaceutical annual long term assets?
  • What is the all time high annual non current assets for Ultragenyx Pharmaceutical?
  • What is Ultragenyx Pharmaceutical annual non current assets year-on-year change?
  • What is Ultragenyx Pharmaceutical quarterly long term assets?
  • What is the all time high quarterly non current assets for Ultragenyx Pharmaceutical?
  • What is Ultragenyx Pharmaceutical quarterly non current assets year-on-year change?

What is Ultragenyx Pharmaceutical annual long term assets?

The current annual non current assets of RARE is $713.90 M

What is the all time high annual non current assets for Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical all-time high annual long term assets is $713.90 M

What is Ultragenyx Pharmaceutical annual non current assets year-on-year change?

Over the past year, RARE annual long term assets has changed by +$52.36 M (+7.91%)

What is Ultragenyx Pharmaceutical quarterly long term assets?

The current quarterly non current assets of RARE is $738.75 M

What is the all time high quarterly non current assets for Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical all-time high quarterly long term assets is $758.83 M

What is Ultragenyx Pharmaceutical quarterly non current assets year-on-year change?

Over the past year, RARE quarterly long term assets has changed by +$99.80 M (+15.62%)